ImmunoGen Announces Webcast of Presentation and Q&A at the 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

ImmunoGen Inc. (Nasdaq: IMGN) announced that CEO Mark Enyedy will present at the 39th Annual J.P. Morgan Virtual Healthcare Conference on January 13, 2021, at 10:50 AM ET. Following the presentation, a Q&A session will take place at 11:10 AM ET, featuring Enyedy and management. A live webcast of both events will be accessible via the Investors & Media section on ImmunoGen's website, with a replay available afterward. ImmunoGen specializes in developing advanced antibody-drug conjugates aimed at improving cancer patient outcomes.

Positive

• Participation in a high-profile investor conference enhances visibility.
• Focus on innovative antibody-drug conjugates indicates a commitment to cancer treatment advancements.

Negative

• None.

ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that Mark Enyedy, President and CEO, will present at the upcoming 39^th Annual J.P. Morgan Virtual Healthcare Conference. The presentation is scheduled for 10:50am ET on January 13, 2021.

Following the presentation, Mr. Enyedy will be joined by other members of ImmunoGen’s management team for a question-and-answer session at 11:10am ET.

A webcast of the presentation and question-and-answer session will be accessible live through the “Investors & Media” section of the Company’s website, www.immunogen.com; a replay will be available in the same location.

ABOUT IMMUNOGEN

ImmunoGen is developing the next generation of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, we aim to disrupt the progression of cancer and offer our patients more good days. We call this our commitment to “target a better now.”

Learn more about who we are, what we do, and how we do it at www.immunogen.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201230005005/en/

FAQ

When is the ImmunoGen presentation at the J.P. Morgan Virtual Healthcare Conference?

ImmunoGen's presentation is scheduled for January 13, 2021, at 10:50 AM ET.

Who will present at the J.P. Morgan Virtual Healthcare Conference for ImmunoGen?

Mark Enyedy, President and CEO of ImmunoGen, will present.

Is there a Q&A session after the ImmunoGen presentation?

Yes, a Q&A session will follow the presentation at 11:10 AM ET.

Where can I watch the ImmunoGen presentation?

The presentation will be accessible live through the Investors & Media section of ImmunoGen's website.

What is ImmunoGen's focus in cancer treatment?

ImmunoGen is focused on developing antibody-drug conjugates to improve cancer treatment outcomes.